跳至主要内容
临床试验/NCT03564106
NCT03564106已完成2 期

Comparison Between Intra-articular Pulsed Radiofrequency With Steroids Injection Versus Intra-articular Steroids Injection in Chronic Sacroiliac Joint Arthritis

Assiut University1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2019年3月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
40
试验地点
1
主要终点
pain intensity

研究概览

简要总结

The sacroiliac joint is Located between the pelvis and base of the spine, the sacroiliac joints are strong, stable joints that allow for little movement. While these joints do not bend like a knuckle or knee, they are susceptible to degenerative arthritis. Sacroiliac joint pain is one of the most common causes of chronic low back pain, accounting for 10% to 27% of patients with chronic lower back pain. It is known to be caused by abnormal motion in this joint, namely, too much motion or too little motion. Patients with pain experience various degrees of pain in the low back, groin, buttock, or posterior thigh.

详细描述

The pain starts when the Sacroiliac joint gets inflamed. There are several reasons it could happen. It could be hurt when playing sports or if fall down.

Sometimes start hurting when the ligaments that hold the SI joint together are damaged, which may make the joint move abnormally. The pain associated with sacroiliitis most commonly occurs in the buttocks and lower back. It can also affect the legs, groin and even the feet.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients must have chronic pain more than 6 months and have failed medical treatment.

排除标准

  • Infection at the site of injection
  • Opioids addiction
  • Coagulopathy or another bleeding diathesis
  • Those who refuse to participate in the study
  • Ankylosing Spondylitis patients

研究组 & 干预措施

group A

Experimental

receive intraarticular radiofrequency + methylprednisolone (30 mg)

干预措施: intraarticular radiofrequency + intraarticular methylprednisolone (Drug)

group C

Experimental

receive intraarticular methylprednisolone (30 mg)

干预措施: intraarticular methylprednisolone (Drug)

结局指标

主要结局

pain intensity

时间窗: up to 6 months

Numeric Rating Scale (NRS)

次要结局

  • Pain Disability(up to 6 months)
  • Patient Impression(up to 6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ghada Mohammed AboelFadl

Principal Investigator

Assiut University

研究点 (1)

Loading locations...

相似试验